{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:59:31Z","timestamp":1790917171867,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2004,9,15]],"date-time":"2004-09-15T00:00:00Z","timestamp":1095206400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1038\/sj.npp.1300555","type":"journal-article","created":{"date-parts":[[2004,9,15]],"date-time":"2004-09-15T11:40:07Z","timestamp":1095248407000},"page":"2235-2241","source":"Crossref","is-referenced-by-count":62,"title":["Decreased Hippocampal 5-HT2A Receptor Binding in Older Depressed Patients Using [18F]Altanserin Positron Emission Tomography"],"prefix":"10.1038","volume":"29","author":[{"given":"Yvette I","family":"Sheline","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Mintun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna M","family":"Barch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham Z","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M","family":"Moerlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,9,15]]},"reference":[{"key":"BF1300555_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0006-3223(98)00007-9","volume":"45","author":"D Attar-Levy","year":"1999","unstructured":"Attar-Levy D, Martinot JL, Blin J, Dao-Castellana MH, Crouzel C, Mazoyer B et al (1999). The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine. Biol Psychiatry 45: 180\u2013186.","journal-title":"Biol Psychiatry"},{"key":"BF1300555_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1600-0447.1981.tb00796.x","volume":"64","author":"M Baron","year":"1981","unstructured":"Baron M, Mendlewicz J, Klotz J (1981). Age-of-onset and genetic transmission in affective disorders. Acta Psychiatr Scand 64: 373\u2013380.","journal-title":"Acta Psychiatr Scand"},{"key":"BF1300555_CR3","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1176\/appi.ajp.159.8.1424","volume":"159","author":"S Bell-McGinty","year":"2002","unstructured":"Bell-McGinty S, Butters MA, Meltzer CC, Greer PJ, Reynolds III CF, Becker JT (2002). Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry 159: 1424\u20131427.","journal-title":"Am J Psychiatry"},{"key":"BF1300555_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0969-8051(97)00054-1","volume":"24","author":"F Biver","year":"1997","unstructured":"Biver F, Lotstra F, Monclus M, Dethy S, Damhaut P, Wikler D et al (1997a). In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: a film and electronic autoradiographic study. Nucl Med Biol 24: 357\u2013360.","journal-title":"Nucl Med Biol"},{"key":"BF1300555_CR5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1192\/bjp.171.5.444","volume":"171","author":"F Biver","year":"1997","unstructured":"Biver F, Wikler D, Lotstra F, Damhaut P, Goldman S, Mendlewicz J (1997b). Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry 171: 444\u2013448.","journal-title":"Br J Psychiatry"},{"key":"BF1300555_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1176\/ajp.157.1.115","volume":"157","author":"JD Bremner","year":"2000","unstructured":"Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS (2000). Hippocampal volume reduction in major depression. Am J Psychiatry 157: 115\u2013118.","journal-title":"Am J Psychiatry"},{"key":"BF1300555_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-0173(93)90005-K","volume":"18","author":"F Chaouloff","year":"1993","unstructured":"Chaouloff F (1993). Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Brain Res Rev 18: 1\u201332.","journal-title":"Brain Res Brain Res Rev"},{"key":"BF1300555_CR8","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1001\/archpsyc.1981.01780350094011","volume":"38","author":"DS Charney","year":"1981","unstructured":"Charney DS, Menkes DB, Heninger GR (1981). Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. Arch Gen Psychiatry 38: 1160\u20131180.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300555_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/0006-8993(88)91621-6","volume":"443","author":"SC Cheetham","year":"1988","unstructured":"Cheetham SC, Crompton MR, Katona CL, Horton RW (1988). Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res 443: 272\u2013280.","journal-title":"Brain Res"},{"key":"BF1300555_CR10","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/0028-3908(84)90100-X","volume":"23","author":"TJ Crow","year":"1984","unstructured":"Crow TJ, Cross AJ, Cooper SJ, Deakin JF, Ferrier IN, Johnson JA et al (1984). Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 23: 1561\u20131569.","journal-title":"Neuropharmacology"},{"key":"BF1300555_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/archpsyc.1997.01830190015002","volume":"54","author":"RS Duman","year":"1997","unstructured":"Duman RS, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression. Arch Gen Psychiatry 54: 597\u2013606.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300555_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF1300555_CR13","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1192\/bjp.139.4.288","volume":"139","author":"RJ Jacoby","year":"1981","unstructured":"Jacoby RJ, Levy R, Bird JM (1981). Computed tomography and the outcome of affective disorder: a follow-up study of elderly patients. Br J Psychiatry 139: 288\u2013292.","journal-title":"Br J Psychiatry"},{"key":"BF1300555_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0006-8993(93)90878-Q","volume":"609","author":"RM Kesser","year":"1993","unstructured":"Kesser RM, Whetsell WO, Ansari MS, Votaw JR, de Paulis T, Clanton JA et al (1993). Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride. Brain Res 609: 237\u2013243.","journal-title":"Brain Res"},{"key":"BF1300555_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1176\/ajp.154.4.497","volume":"154","author":"K Krishnan","year":"1997","unstructured":"Krishnan K, Hays J, Blazer D (1997). MRI-Defined vascular depression. Am J Psychiatry 154: 497\u2013501.","journal-title":"Am J Psychiatry"},{"key":"BF1300555_CR16","first-page":"80","volume":"14","author":"O Kuchel","year":"1991","unstructured":"Kuchel O (1991). Stress and catecholamines. Methods Achiev Exp Pathol 14: 80\u2013103.","journal-title":"Methods Achiev Exp Pathol"},{"key":"BF1300555_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1055\/s-0038-1625925","volume":"40","author":"R Larisch","year":"2001","unstructured":"Larisch R, Klimke A, Mayoral F, Hamacher K, Herzog HR, Vosberg H et al (2001). Disturbance of serotonin 5HT2 receptors in remitted patients suffering from hereditary depressive disorder. Nuklearmedizin 40: 129\u2013134.","journal-title":"Nuklearmedizin"},{"key":"BF1300555_CR18","first-page":"2266","volume":"32","author":"C Lemaire","year":"1991","unstructured":"Lemaire C, Cantineau R, Guillaume M, Plenevaux A, Christiaens L (1991). Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. J Nucl Med 32: 2266\u20132272.","journal-title":"J Nucl Med"},{"key":"BF1300555_CR19","first-page":"31","volume-title":"Serotonin Receptor Subtypes: Pharmacological Significance and Clinical Implications","author":"JE Leysen","year":"1992","unstructured":"Leysen JE (1992). 5HT2A-receptors: location, pharmacological, pathological and physiological role. In: Langer SZ, Brunello N, Racagni G, Mendlewicz J (eds). Serotonin Receptor Subtypes: Pharmacological Significance and Clinical Implications. Basel: Karger. pp 31\u201343."},{"key":"BF1300555_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0006-8993(94)90932-6","volume":"642","author":"S Lowther","year":"1994","unstructured":"Lowther S, De Paermentier F, Crompton MR, Katona CL, Horton RW (1994). Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment. Brain Res 642: 281\u2013289.","journal-title":"Brain Res"},{"key":"BF1300555_CR21","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1073\/pnas.0337481100","volume":"100","author":"GM MacQueen","year":"2003","unstructured":"MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT et al (2003). Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 100: 1387\u20131392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1300555_CR22","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1176\/ajp.156.12.1871","volume":"156","author":"CC Meltzer","year":"1999","unstructured":"Meltzer CC, Price JC, Mathis CA, Greer PJ, Cantwell MN, Houck PR et al (1999). PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. Am J Psychiatry 156: 1871\u20131878.","journal-title":"Am J Psychiatry"},{"key":"BF1300555_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1176\/appi.ajp.158.1.78","volume":"158","author":"JH Meyer","year":"2001","unstructured":"Meyer JH, Kapur S, Eisfeld B, Brown GM, Houle S, DaSilva J et al (2001). The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am J Psychiatry 158: 78\u201385.","journal-title":"Am J Psychiatry"},{"key":"BF1300555_CR24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/ajp.156.7.1029","volume":"156","author":"JH Meyer","year":"1999","unstructured":"Meyer JH, Kapur S, Houle S, DaSilva J, Owczarek B, Brown GM et al (1999). Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. Am J Psychiatry 156: 1029\u20131034.","journal-title":"Am J Psychiatry"},{"key":"BF1300555_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.biopsych.2003.08.015","volume":"55","author":"MA Mintun","year":"2004","unstructured":"Mintun MA, Sheline YI, Moerlein SM, Vlassenko AG, Huang Y, Snyder AZ (2004). Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F] altanserin positron emission tomography. Biol Psychiatry 55: 217\u2013224.","journal-title":"Biol Psychiatry"},{"key":"BF1300555_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0969-8051(97)00042-5","volume":"24","author":"SM Moerlein","year":"1997","unstructured":"Moerlein SM, Perlmutter JS, Cutler PD, Welch MJ (1997). Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates. Nucl Med Biol 24: 311\u2013318.","journal-title":"Nucl Med Biol"},{"key":"BF1300555_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1006\/nimg.2000.0619","volume":"12","author":"RM Moresco","year":"2000","unstructured":"Moresco RM, Colombo C, Fazio F, Bonfanti A, Lucignani G, Messa C et al (2000). Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: a PET study. Neuroimage 12: 452\u2013465.","journal-title":"Neuroimage"},{"key":"BF1300555_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0306-4522(87)90327-7","volume":"21","author":"A Pazos","year":"1987","unstructured":"Pazos A, Probst A, Palacios JM (1987a). Serotonin receptors in the human brain\u2014IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21: 123\u2013139.","journal-title":"Neuroscience"},{"key":"BF1300555_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0306-4522(87)90326-5","volume":"21","author":"A Pazos","year":"1987","unstructured":"Pazos A, Probst A, Palacios JM (1987b). Serotonin receptors in the human brain\u2014III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21: 97\u2013122.","journal-title":"Neuroscience"},{"key":"BF1300555_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0925-4927(00)00076-7","volume":"99","author":"P Rosel","year":"2000","unstructured":"Rosel P, Arranz B, San L, Vallejo J, Crespo JM, Urretavizcaya M et al (2000). Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victims. Psychiatry Res 99: 173\u2013181.","journal-title":"Psychiatry Res"},{"key":"BF1300555_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0925-4927(98)00015-8","volume":"82","author":"P Rosel","year":"1998","unstructured":"Rosel P, Arranz B, Vallejo J, Oros M, Crespo JM, Menchon JM et al (1998). Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains. Psychiatry Res 82: 161\u2013170.","journal-title":"Psychiatry Res"},{"key":"BF1300555_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1176\/appi.ajp.159.3.430","volume":"159","author":"YI Sheline","year":"2002","unstructured":"Sheline YI, Mintun MA, Moerlein SM, Snyder AZ (2002). Greater loss of 5-HT(2A) receptors in midlife than in late life. Am J Psychiatry 159: 430\u2013435.","journal-title":"Am J Psychiatry"},{"key":"BF1300555_CR33","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1523\/JNEUROSCI.19-12-05034.1999","volume":"19","author":"YI Sheline","year":"1999","unstructured":"Sheline YI, Sanghavi M, Mintun MA, Gado MH (1999). Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19: 5034\u20135043.","journal-title":"J Neurosci"},{"key":"BF1300555_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0006-3223(03)00181-1","volume":"54","author":"E Shimizu","year":"2003","unstructured":"Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C et al (2003). Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54: 70\u201375.","journal-title":"Biol Psychiatry"},{"key":"BF1300555_CR35","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/(SICI)1098-2396(199812)30:4<380::AID-SYN5>3.0.CO;2-U","volume":"30","author":"GS Smith","year":"1998","unstructured":"Smith GS, Price JC, Lopresti BJ, Huang Y, Simpson N, Holt D et al (1998). Test\u2013retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain. Synapse 30: 380\u2013392.","journal-title":"Synapse"},{"key":"BF1300555_CR36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0969-8051(99)00022-0","volume":"26","author":"PZ Tan","year":"1999","unstructured":"Tan PZ, Baldwin RM, van Dyck CH, Al Tikriti M, Roth B, Khan N et al (1999). Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent. Nucl Med Biol 26: 601\u2013608.","journal-title":"Nucl Med Biol"},{"key":"BF1300555_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3940(99)00006-3","volume":"287","author":"VA Vaidya","year":"1999","unstructured":"Vaidya VA, Duman RS (1999). Role of 5-HT2A receptors in down-regulation of BDNF by stress. Neurosci Lett 287: 1\u20134.","journal-title":"Neurosci Lett"},{"key":"BF1300555_CR38","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","volume":"17","author":"VA Vaidya","year":"1997","unstructured":"Vaidya VA, Marek GJ, Aghajanian GK, Duman RS (1997). 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 17: 2785\u20132795.","journal-title":"J Neurosci"},{"key":"BF1300555_CR39","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1192\/bjp.178.5.448","volume":"178","author":"LN Yatham","year":"2001","unstructured":"Yatham LN, Liddle PF, Shiah IS, Lam RW, Adam MJ, Zis AP et al (2001). Effects of rapid tryptophan depletion on brain 5-HT(2) receptors: a PET study. Br J Psychiatry 178: 448\u2013453.","journal-title":"Br J Psychiatry"},{"key":"BF1300555_CR40","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1001\/archpsyc.57.9.850","volume":"57","author":"LN Yatham","year":"2000","unstructured":"Yatham LN, Liddle PF, Shiah IS, Scarrow G, Lam RW, Adam MJ (2000). Brain serotonin 2 receptors in major depression: a positron emission tomography study. Arch Gen Psychiatry 57: 850\u2013858.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300555_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00004714-200102000-00010","volume":"21","author":"R Zanardi","year":"2001","unstructured":"Zanardi R, Artigas F, Moresco R, Colombo C, Messa C, Gobbo C et al (2001). Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. J Clin Psychopharmacol 21: 53\u201358.","journal-title":"J Clin Psychopharmacol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300555","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T10:40:25Z","timestamp":1705228825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,15]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["BF1300555"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300555","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,15]]}}}